Username:
Cipla was established in 1935 with the vision of making India self-reliant and self-sufficient in healthcare. Today, we are one of the world's largest generic pharmaceutical companies with a presence in over 170 countries. We are renowned for making affordable, world-class medicines that meet the needs of patients across therapies. We also offer services like consulting, commissioning, plant engineering, technical know-how transfer and support.
Incorporated | 1935 |
Corporate Office | Cipla Ltd., Mumbai Central, Mumbai 400 008, India |
Chairman | Dr. Yusuf K. Hamied |
Executive Vice-Chairman | Mr. M.K. Hamied |
Listing |
Equity Shares: BSE Limited and National Stock Exchange of India Limited Global Depository Receipts: Luxembourg Stock Exchange |
Turnover* | USD 1.5 billion |
Employees* | 20,000 |
Approvals | US FDA, WHO-Geneva, MHRA-UK, TGA-Australia, SUKL-Slovak Republic, APVMA-Australia, MCC-South Africa, PIC-Germany, Danish Medical Agency, ANVISA-Brazil, INVIMA- Colombia, NDA-Uganda, Department of Health-Canada and MOH-Saudi Arabia, among others |
Highlights |
|
Contact |
contactus@cipla.com +91 22 23082891, +91 22 23095521 |